Mirvetuximab Enrolling by Invitation Phase 1 Trials for Platinum-Resistant Primary Peritoneal Carcinoma / Primary Peritoneal Carcinoma / Platinum-resistant Ovarian Cancer / Ovarian Cancer / platinum drug resistant Fallopian tube cancer / Fallopian Tube Cancer / Epithelial Ovarian Cancer Treatment